Body Composition Differences Between Excess Weight Loss ≥ 50% and < 50% at 12 Months Following Bariatric Surgery.
Bariatric surgery
Body composition
Weight loss
Journal
Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
received:
28
01
2022
accepted:
25
05
2022
revised:
20
05
2022
pubmed:
2
6
2022
medline:
14
7
2022
entrez:
1
6
2022
Statut:
ppublish
Résumé
The relationship between weight loss and body composition is undefined after bariatric surgery. The objective of this study was to compare body composition changes in patients with excess weight loss ≥ 50% (EWL ≥ 50) and < 50% at 12 months post-operatively (EWL < 50). A prospective cohort study was completed on patients undergoing bariatric surgery at two tertiary hospitals between 2017 and 2021. Body composition was measured with dual-energy X-ray absorptiometry immediately before surgery, and at 1, 6, and 12 months post-operatively. Body mass index (BMI), fat mass (FM), lean body mass (LBM), and skeletal muscle index (SMI) trajectories were analysed between patients with EWL ≥ 50% and EWL < 50%. Thirty-seven patients were included in this series (EWL ≥ 50% n = 25, EWL < 50% n = 12), comprising of both primary and revisional bariatric surgery cases, undergoing a sleeve gastrectomy (62.2%), Roux-en-Y gastric bypass (32.4%), or one anastomosis gastric bypass (5.4%). The EWL ≥ 50% group demonstrated a more optimal mean FM-to-LBM loss ratio than the EWL < 50% group. EWL ≥ 50% patients lost 2.0 kg more FM than EWL < 50% patients for each 1 kg of LBM lost. EWL ≥ 50% was also associated with an increase in mean SMI% over 12 months (5.5 vs. 2.4%; p < 0.0009). Across the whole cohort, the first month after surgery accounted for 67.4% of the total LBM reduction that occurred during the 12-month post-operative period. This data suggests EWL ≥ 50% is associated with a more optimal body composition outcome than EWL < 50%. LBM reduction occurs predominantly in the early post-operative period.
Sections du résumé
BACKGROUND
The relationship between weight loss and body composition is undefined after bariatric surgery. The objective of this study was to compare body composition changes in patients with excess weight loss ≥ 50% (EWL ≥ 50) and < 50% at 12 months post-operatively (EWL < 50).
METHODS
A prospective cohort study was completed on patients undergoing bariatric surgery at two tertiary hospitals between 2017 and 2021. Body composition was measured with dual-energy X-ray absorptiometry immediately before surgery, and at 1, 6, and 12 months post-operatively. Body mass index (BMI), fat mass (FM), lean body mass (LBM), and skeletal muscle index (SMI) trajectories were analysed between patients with EWL ≥ 50% and EWL < 50%.
RESULTS
Thirty-seven patients were included in this series (EWL ≥ 50% n = 25, EWL < 50% n = 12), comprising of both primary and revisional bariatric surgery cases, undergoing a sleeve gastrectomy (62.2%), Roux-en-Y gastric bypass (32.4%), or one anastomosis gastric bypass (5.4%). The EWL ≥ 50% group demonstrated a more optimal mean FM-to-LBM loss ratio than the EWL < 50% group. EWL ≥ 50% patients lost 2.0 kg more FM than EWL < 50% patients for each 1 kg of LBM lost. EWL ≥ 50% was also associated with an increase in mean SMI% over 12 months (5.5 vs. 2.4%; p < 0.0009). Across the whole cohort, the first month after surgery accounted for 67.4% of the total LBM reduction that occurred during the 12-month post-operative period.
CONCLUSION
This data suggests EWL ≥ 50% is associated with a more optimal body composition outcome than EWL < 50%. LBM reduction occurs predominantly in the early post-operative period.
Identifiants
pubmed: 35648364
doi: 10.1007/s11695-022-06128-3
pii: 10.1007/s11695-022-06128-3
pmc: PMC9156838
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2556-2566Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Surg Obes Relat Dis. 2019 Nov;15(11):1965-1973
pubmed: 31519485
Rocz Panstw Zakl Hig. 2015;66(1):13-9
pubmed: 25813068
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Obes Surg. 2009 Jul;19(7):856-9
pubmed: 19399563
Am J Med. 2009 Mar;122(3):248-256.e5
pubmed: 19272486
Obes Surg. 2021 Aug;31(8):3799-3821
pubmed: 34089442
J Clin Endocrinol Metab. 2006 Nov;91(11):4223-31
pubmed: 16954156
J Appl Physiol (1985). 2010 Sep;109(3):786-95
pubmed: 20558754
Exerc Sport Sci Rev. 2013 Jan;41(1):26-35
pubmed: 22710705
Aust Fam Physician. 2013 Aug;42(8):547-52
pubmed: 23971062
Scand J Surg. 2017 Mar;106(1):40-46
pubmed: 27114108
Int J Obes (Lond). 2005 Mar;29(3):287-91
pubmed: 15672106
Int J Obes Relat Metab Disord. 2004 Jan;28(1):180-2
pubmed: 14610532
Clin Nutr. 2013 Aug;32(4):550-5
pubmed: 23200926
Obes Sci Pract. 2016 Jun;2(2):162-173
pubmed: 27840689
Int J Obes (Lond). 2013 Jun;37(6):759-64
pubmed: 22846776
Obes Surg. 2010 Jul;20(7):861-70
pubmed: 20440579
J Obes. 2013;2013:729515
pubmed: 24455214
Obes Surg. 2020 May;30(5):2015-2020
pubmed: 32124217
Obes Surg. 2015 Dec;25(12):2344-51
pubmed: 25948283
Metabolism. 2015 Aug;64(8):896-904
pubmed: 25908563
Obes Rev. 2021 Jul;22 Suppl 4:e13296
pubmed: 34080281
Adv Nutr. 2017 Mar 15;8(2):382-394
pubmed: 28298280
J Gastrointest Surg. 2015 Oct;19(10):1758-62
pubmed: 26268956
Obes Surg. 2000 Jun;10(3):203-13
pubmed: 10932257
PLoS One. 2018 May 14;13(5):e0197248
pubmed: 29758061
Obes Surg. 2019 Nov;29(11):3493-3499
pubmed: 31256357
Obes Facts. 2013;6(5):449-68
pubmed: 24135948
Obes Surg. 2015 Nov;25(11):2093-9
pubmed: 26055550
Appl Physiol Nutr Metab. 2009 Jun;34(3):403-10
pubmed: 19448706
Obesity (Silver Spring). 2009 Jun;17(6):1281-6
pubmed: 19584885
J Clin Endocrinol Metab. 2019 Mar 1;104(3):711-720
pubmed: 30657952
Br J Nutr. 2020 Dec 14;124(11):1121-1132
pubmed: 32576318
Int J Obes (Lond). 2007 May;31(5):743-50
pubmed: 17075583
Obes Surg. 2018 Aug;28(8):2297-2304
pubmed: 29484610
PLoS One. 2014 Dec 17;9(12):e115407
pubmed: 25517117
BMC Surg. 2019 Sep 5;19(1):127
pubmed: 31488115
BMJ Open. 2021 Jun 24;11(6):e045975
pubmed: 34168026
Diabetes Metab. 2015 Nov;41(5):416-21
pubmed: 26022386
Obes Surg. 2018 Mar;28(3):864-868
pubmed: 29264782
Int J Obes (Lond). 2009 Mar;33(3):289-95
pubmed: 19188927
J Clin Endocrinol Metab. 2010 Nov;95(11):4823-43
pubmed: 21051578
Obes Surg. 2016 Aug;26(8):1659-96
pubmed: 27412673
Obes Surg. 2021 Jan;31(1):384-393
pubmed: 33159294
Obes Rev. 2014 Apr;15(4):310-21
pubmed: 24447775
Diabetes Obes Metab. 2016 Jan;18(1):16-23
pubmed: 26228356
Obes Surg. 2016 Mar;26(3):479-85
pubmed: 26189734
J Endocrinol Invest. 2021 May;44(5):1021-1029
pubmed: 32840764
Obes Surg. 2022 Mar;32(3):625-633
pubmed: 34846686
Obesity (Silver Spring). 2013 Mar;21 Suppl 1:S1-27
pubmed: 23529939
Metab Syndr Relat Disord. 2010 Feb;8(1):15-20
pubmed: 19929598
Surg Endosc. 2020 Jun;34(6):2332-2358
pubmed: 32328827
Obes Surg. 2008 Jan;18(1):1-4
pubmed: 18080722
Obes Surg. 2011 Nov;21(11):1798-805
pubmed: 21590346
Int J Obes (Lond). 2017 Sep;41(9):1379-1387
pubmed: 28584299
Obes Res Clin Pract. 2007 Jan;1(1):1-78
pubmed: 24351427